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Aim: The aim of this study was to compare the frequencies of surgical interventions between patients receiving intraarticular hyaluronic
acid (IAHA) injection and those receiving only oral antiinflammatory drug treatment at the end of a 1-year follow-up period.
Materials and methods: A total of 705 patients diagnosed with knee osteoarthritis (OA) between 2007 and 2009 were included in this
study. Their records were investigated retrospectively. We divided 218 of the patients into 3 groups according to the Kellgren–Lawrence
criteria, and they received sodium hyaluronate once a week for 3 weeks. Another 487 patients with gonarthrosis served as group 2 and
were treated with nonsteroidal oral antiinflammatory drugs and exercises. The surgical rates between the IAHA groups and the control
groups were compared. The groups with the 2 different treatment modalities were compared according to the surgical operation rates
at the end of a 1-year period.
Results: While 9 of the 68 IAHA-treated patients with grade 2 OA had a surgical intervention within the year, 22 of the 172 patients
with grade 2 OA in group 2 were operated on (13.2% versus 12.8%, P = 0.927). A surgical intervention was performed in 7 of the 78
IAHA-treated patients with grade 3 OA at the end of 1 year, and in 18 of the 164 patients with grade 3 OA (group 2) (8.9% versus 10.9%,
P = 0.629). Of the 51 IAHA-treated patients with grade 4 OA, 4 underwent a surgical intervention within the year, whereas 22 of the 151
patients in group 2 were operated on (7.8% versus 14.6%, P = 0.222).
Conclusion: Although there was no statistically significant difference between the groups, a lower percentage of IAHA-treated patients
with grade 4 OA underwent surgical interventions. At the end of 1 year, the rates of surgical operations between the patients receiving
IAHA and antiinflammatory treatment in the other 2 groups (knee grades 2 and 3 OA) showed no statistically significant difference.
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1. Introduction
Osteoarthritis (OA) is the most common form of arthritis
(1). Approximately one-third of all adults have radiological
signs of OA (2). However, clinically significant OA of the
knees, hands, and hips was reported in 8.9% of the adult
population (3). It is most commonly seen in the knee joint.
Obesity, anatomic abnormalities, and loss of joint stability
set abnormal stresses on the joint and can lead to cartilage
changes and degradation. Aging, genetic predisposition,
inﬂammation, and immune system activity can also play a
role in abnormal cartilage changes (4).
Patients suffering from OA might complain of pain,
muscle weakness, a limited range of motion, and increasing
disability (5). The aim of treatment is to reduce pain, stop
* Correspondence: doktormuratkorkmaz@hotmail.com
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damage to the cartilage, and increase the range of motion.
Patient education, weight loss, physiotherapy and exercise,
assisting devices, pharmacological therapies, and surgery
are the treatment modalities used in gonarthrosis (6).
OA is often treated with nonsteroidal antiinflammatory
drugs (NSAIDs) (7,8). Diclofenac sodium is the most
frequently used NSAID in the treatment of OA. The
efficacy of diclofenac sodium is largely unchallenged in
that it remains as effective as newer pain relief medications
employed in OA (9).
One conservative treatment modality in gonarthrosis
is hyaluronic acid (HA) injection. The surfaces of the
cartilage and synovial membrane are coated with HA
(10). HA also plays a particular role in synovial ﬂuid,
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giving it its shock-absorbing and viscoelastic properties
(11). Incomplete synthesis and increased production
of incompletely polymerized HA have been postulated
as possible explanations of OA (12). Initially, repeated
courses of intraarticular hyaluronic acid (IAHA) injection
had been accepted as effective and safe in the treatment
of gonarthrosis and other diseases (13–17). However,
in recent years, studies found that IAHA had no effect
in the treatment of OA (18,19). In another study, IAHA
treatment could prolong the time to surgery in patients
with gonarthrosis that did not respond to conservative
treatment (20).
This study aimed to compare the frequencies of
surgical interventions between patients receiving IAHA
injections and those receiving only oral antiinflammatory
drug treatment at the end of a 1-year follow-up period.
The relationship between the surgical operation rates and
grade of OA was investigated.
2. Materials and methods
A total of 705 patients with knee pain, diagnosed between
January 2007 and June 2009, were included in the study.
All of them had a diagnosis of knee OA according to the
American College of Rheumatology (ACR) criteria (21).
Standing radiographic images of the knee joint from
anteroposterior and lateral aspects were performed and
the patients were divided into 3 groups according to the
Kellgren–Lawrence criteria (KLC) (22) (Table 1). Exclusion
criteria were as follows: a) intraarticular injection history
in the previous 3 months, b) arthroscopic intervention in
the previous year, and c) history of pain occurrence related
to intraarticular injection.
Group 1 initially consisted of 218 patients who received
25 mg of sodium hyaluronate (Adant®, 25 mg of sodium
hyaluronate dissolved in 2.5 mL of physiological saline,
Meiji-Seika Kaisha, Japan) once a week for 3 weeks. Due
to pain or swelling and effusion occurrence after the first
IAHA injection, 21 patients (9.6%) were excluded from the
study. Therefore, group 1 finally comprised 197 patients.
According to ACR criteria, group 2 consisted of 487
patients with gonarthrosis. These patients received only
medical treatment with NSAID oral drugs (diclofenac
sodium in doses of 75 mg twice daily for 10 days) and
exercise. These participants were also divided into 3 groups
according to the KLC (Table 1).

In all groups, surgical decisions were made based on
the conditions of persisting pain, limitation of movements
in the knees, and unresponsiveness to given medical
treatment. The operation rates between IAHA groups and
NSAID groups were compared statistically.
SPSS 15.0 was used for statistical analysis and the
variables were compared by using chi-square and Friedman
tests. Values less than 0.05 were considered significant.
3. Results
Demographic data of the patients in all groups are shown
in Table 2
Of the 68 patients (13.2%) with grade 2 OA (group 1),
9 had a surgical intervention after 1 year (1 meniscal tear,
8 cartilage-related problems), whereas 22 of 172 patients
(12.8%) with grade 2 OA in group 2 were operated on
within the year (6 meniscal tears, 16 cartilage-related
problems). There was no significant difference between
the groups (P = 0.926). All operations were performed
arthroscopically with debridement and washing (Table 3).
A surgical intervention was done in 7 (8.9%) of 78
patients from group 1 with grade 3 OA at the end of
1 year (4 cartilage-related problems with arthroscopic
debridement and washing, 3 total knee prostheses). In the
NSAID group, 18 (10.9%) of 164 patients with grade 3 OA
were operated on (2 meniscal tears, 12 cartilage-related
problems, and 4 total knee prostheses). The difference was
not statistically significant (P = 0.629). Arthroscopy was
performed on patients not responding to conservative
treatment. The patients who had severe cartilage defects
in arthroscopy and were not satisfied with the operation
underwent knee prosthesis operation within 3 months
(Table 3).
In group 1, 4 of 51 patients with grade 4 OA (7.8%)
underwent a surgical intervention within the year, whereas
22 of 151 patients (14.6%) with grade 4 OA from group
2 were operated on. Although the observed operation
frequency in patients with grade 4 OA was 6.8% less
than that in grade 4 OA patients of the control group, the
difference was not statistically significant (P = 0.222). In
all of these patients, a total knee prosthesis operation was
performed (Table 3). The decision to perform a surgical
intervention was made for patients with night pain,
walking pain, and limited walking distances.

Table 1. Kellgren–Lawrence criteria.
Grade 1: Doubtful narrowing of joint space and possible osteophytic lipping.
Grade 2: Definite osteophytes, definite narrowing of joint space.
Grade 3: Moderate multiple osteophytes, definite narrowing of joints space, some sclerosis and possible deformity of bone contour.
Grade 4: Large osteophytes, marked narrowing of joint space, severe sclerosis and definite deformity of bone contour.
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Table 2. Demographic data of study groups. SD: Standard deviation, Grade: according to Kellgren–Lawrence criteria.
Group 1

Age, mean (SD), years

Group 2

Grade 2

Grade 3

Grade 4

Grade 2

Grade 3

Grade 4

n = 68

n = 78

n = 51

n = 172

n = 164

n = 151

52 (11.8)

56 (10.2)

68 (13.3)

49 (11.8)

53 (10.6)

61 (12.2)

61 (92.8)

67 (85.8)

33 (64.7)

159 (92.4)

143 (87.1)

109 (72.1)

7 (7.2)

11 (14.2)

18 (35.3)

13 (7.6)

21 (12.9)

42 (27.9)

Sex
Female, n (%)
Male, n (%)

Table 3. Treatment results of study groups. IAHA: intraarticular hyaluronic acid injection. NSAID: nonsteroidal antiinflammatory
drugs. Grade: according to Kellgren–Lawrence criteria.
Treatment

Surgical treatment

IAHA

NSAID

Arthroscopy

Total knee replacement

Total

n

%

n

%

n

%

n

%

n

%

2

59

86.8

0

0

9

13.2

0

0.0

68

100

3

71

91.0

0

0

4

5.2

3

3.8

78

100

4

47

92.2

0

0

0

0.0

4

7.8

51

100

Total

177

89.8

0

0

13

6.6

7

3.6

197

100

2

0

0

150

87.2

22

12.8

0

0.0

172

100

3

0

0

146

89.0

14

8.5

4

2.5

164

100

4

0

0

129

85.4

0

0.0

22

14.6

151

100

Total

0

0

425

97.3

36

7.4

26

5.3

487

100

Group 1 grade

Group 2 grade

4. Discussion
According to international guidelines for knee symptoms,
NSAIDs should be the first choice of medication for pain
relief in osteoarthritis. Of all prescribed pain medication in
general practice, 90% consists of nonsteroidal antiinflammatory drugs (23). Diclofenac is a commonly prescribed
NSAID for pain relief in OA. A review of the available data
demonstrates that diclofenac continues to provide physicians with a benchmark pharmacological treatment for
OA (9). However, long-term use of NSAIDs is also directly
related to many side effects, including gastrointestinal
bleeding, hypertension, congestive heart failure, hyperkalemia, and renal insufficiency (24).
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Although IAHA treatment has been used for years with
promising results, there are conflicting results concerning
this treatment in patients with OA. Altman et al. (25)
compared HA injections to a placebo or oral naproxen
in 495 patients with idiopathic osteoarthritis in a 26week, double-blind masked trial. Patients receiving IAHA
treatment achieved better results than the placebo group
(P < 0.05). At the end of 26 weeks, 47.6% of patients treated
with IAHA had slight pain or were pain-free, compared to
the placebo group or naproxen patients. A metaanalysis
and additional studies also reported on the effectiveness of
IAHA treatment (16,26–28).
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However, another study concluded that IAHA offers
no significant benefit over a placebo during the treatment
period but leads to a significantly higher morbidity, and
therefore has no place in the routine treatment of OA (29).
A study by Jorgenson et al. (18) showed that intraarticular
injections of hyaluronan did not improve pain, function,
paracetamol consumption, or other efﬁcacy parameters in
the following 12-month period.
To our knowledge, there is only one prospective study
that claimed that IAHA treatment could be effective in
delaying the time to total knee replacement in patients with
knee OA that did not respond to conservative treatment.
However, this prospective study by Turajane et al. did not
include a control group (20). In the present study, IAHA
treatment did not reduce the need for surgical intervention
in patients with knee OA. Although the difference between

the operation frequencies of all groups was not statistically
significant, it was 6.8% less in patients with grade 4 OA than
in the controls. This difference was obvious, although not
significant (7.8% versus 14.6% in grade 4 OA and controls
respectively, P = 0.222). IAHA treatment could prolong
the time to surgery, especially in patients with grade 4 OA,
but this effect should be investigated in prospective studies
with more patients.
In conclusion, although not statistically significant, a
lower percentage of IAHA-treated patients with grade 4
OA underwent surgical intervention. At the end of 1 year,
the rates of surgical operations as compared between the
patients receiving IAHA injections and those receiving
antiinflammatory treatment in the other 2 groups (knee
grades 2 and 3 OA) showed no statistically significant
difference.
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